Performance of the SCORTEN in Taiwanese patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

Dermatologica Sinica

Volumn 28, Issue 1, 2010, Pages 15-20

  Ho, Yu Ling ^a   Chang, Yun Ting ^a   Chu, Yu Tseng ^a   Wu, Shiao Chi ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

SCORTEN; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PERFORMANCE; SCORING SYSTEM; SCORTEN FORMULA; STEVENS JOHNSON SYNDROME; TAIWAN; TOXIC EPIDERMAL NECROLYSIS;

EID: 77950587442     PISSN: 10278117     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1027-8117(10)60002-X     Document Type: Article

References (21)

1. Bastuji-Garin S., Fouchard N., Bertocchi M., et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115 (2000) 149-153
2. Pereira F.A., Mudgil A.V., and Rosmarin D.M. Toxic epidermal necrolysis. J Am Acad Dermatol 56 (2007) 181-200
3. Trent J.T., Kirsner R.S., Romanelli P., et al. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. Arch Dermatol 140 (2004) 890-892
4. Trent J.T., Kirsner R.S., Romanelli P., et al. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami experience. Arch Dermatol 139 (2003) 39-43
5. Guegan S., Bastuji-Garin S., Poszepczynska-Guigne E., et al. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol 126 (2006) 272-276
6. Dobson A.J., Kuulasmaa K., Eberle E., et al. Confidence intervals for weighted sums of Poisson parameters. Stat Med 10 (1991) 457-462
7. In: Hosmer D.W., and Lemeshow S. (Eds). Applied logistic regression. 2nd ed. (2000), Wiley-Interscience, New York
8. Lemeshow S., and Hosmer Jr. D.W. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115 (1982) 92-106
9. Cartotto R., Mayich M., Nickerson D., et al. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res 29 (2008) 141-146
10. Imahara S.D., Holmes IV J.H., Heimbach D.M., et al. SCORTEN overestimates mortality in the setting of a standardized treatment protocol. J Burn Care Res 27 (2006) 270-275
11. Stella M., Clemente A., Bollero D., et al. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Burns 33 (2007) 452-459
12. Spornraft-Ragaller P., Theilen H., Gottschlich G.S., et al. Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin. Hautarzt 57 (2006) 185-186 188-90, 192-4. [In German]
13. Kim K.J., Lee D.P., Suh H.S., et al. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients. Acta Derm Venereol 85 (2005) 497-502
14. Lissia M., Figus A., and Rubino C. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report. Br J Plast Surg 58 (2005) 504-510
15. Campione E., Marulli G.C., Carrozzo A.M., et al. High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis. Acta Derm Venereol 83 (2003) 430-432
16. Brown K.M., Silver G.M., Halerz M., et al. Toxic epidermal necrolysis: does immunoglobulin make a difference?. J Burn Care Rehabil 25 (2004) 81-88
17. Gerdts B., Vloemans A.F., and Kreis R.W. Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre. J Eur Acad Dermatol Venereol 21 (2007) 781-788
18. Palmieri T.L., Greenhalgh D.G., Saffle J.R., et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 23 (2002) 87-96
19. Ryan C.M., Schoenfeld D.A., Thorpe W.P., et al. Objective estimates of the probability of death from burn injuries. N Engl J Med 338 (1998) 362-366
20. Vaishampayan S.S., Das A.L., and Verma R. SCORTEN: does it need modification?. Indian J Dermatol Venereol Leprol 74 (2008) 35-37
21. Hague J.S., Goulding J.M., Long T.M., et al. Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN. Br J Dermatol 157 (2007) 1294-1296